METTL3 and nonpapillary renal cell carcinoma: We found METTL3 to be a risk factor associated with poor prognosis of ccRCC, which was consistent with findings in one previous study, but in contrast to those in another study (Li et al., 2017; Chen et al., 2020); thus, the role of MELLT3 in ccRCC remains uncertain.